PART I: Long After Tuskegee, Blacks Still Leary of Clinical Trials

Simple item page
dc.contributor.authorMartin, Pharoh
dc.date.accessioned2019-08-14T15:02:54Z
dc.date.available2019-08-14T15:02:54Z
dc.date.issued2010
dc.description.abstractThe general distrust that African-Americans have of clinical trial research goes back a long way. History tells them that it would be in their best interests to not participate but the reality is that Black participation in clinical research is critical because African-Americans disparately suffer from some of the highest disease rates and respond differently to many treatments. Researchers like Dr. Claudia Baquet, associate professor of epidemiology and preventive medicine at the University of Maryland School of Medicine and director of its National Bioethics Research Center, wants to not only foster public trust among African-Americans for research, but also stress the importance of participating in such research.
dc.description.urihttp://www.theskanner.com/index.php/article/Clinical-Trials-A-Legacy-of-Shame-and-Fear-Being-Addressed-in-2010
dc.identifierhttps://doi.org/10.13016/snfp-8xlx
dc.identifier.citationMartin, Pharoh (2010) PART I: Long After Tuskegee, Blacks Still Leary of Clinical Trials. National Newspaper Publishers Association.
dc.identifier.otherEprint ID 2669
dc.identifier.urihttp://hdl.handle.net/1903/23337
dc.subjectBioethics
dc.subjectResearch
dc.subjectAfrican-Americans
dc.subjectclinical trial research
dc.subjectbioethics
dc.subjectTuskegee Syphillis Experiments
dc.subjectTuskegee
dc.titlePART I: Long After Tuskegee, Blacks Still Leary of Clinical Trials
dc.typeArticle

Files

Collections

Minority Health and Health Equity Archive